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Most contaminants of emerging concern are man-made, and when introducing these 
compounds to consumers and our environment, it comes with a responsibility of obtaining the 
necessary knowledge of their toxicities. Polycyclic aromatic hydrocarbons (PAHs) are organic, 
lipophilic compounds that are carcinogenic and also ubiquitous within our environment. Per- 
and polyfluoroalkyl substances (PFAS) are organic, fluorinated compounds used both in 
industry and consumer products. They are stable and extremely persistent and can cause 
reproductive toxicity and affect metabolism. Toxicity testing has traditionally been performed 
on one compound at a time, but the exposure to wildlife and humans is complex. Mixtures 
might give rise to so-called “cocktail effects”, where the combined response could be 
synergistic, potentiating, or antagonistic. It is important to gain insights into what the effects of 
these compounds might be, and if different combinations of compounds can make an exposure 
scenario more severe for biota. In this thesis Atlantic cod was used as a model organism, and 
precision cut liver slices were exposed ex vivo to three relevant PFAS compounds and 
benzo(a)pyrene. Effects on the Ahr and Ppara-signalling pathways were assessed by gene 
expression analyses of cyp1a, acox1, and acly using qPCR. An Ahr/Arnt/XRE based system was 
also used to study transactivation of the Ahr2a receptor in vitro. All three PFAS congeners were 
able to induce activation of cyp1a on their own, and produced apparent synergistic effects in 
combination with B(a)P. Trends of dose-dependent induction was shown for the expression of 
acly after exposure to PFOA and PFNA, which also induced the expression of acox1. For these 
two Pparα target genes, weak trends of further induction were present after co-exposures 
between all PFAS congeners and B(a)P. As expected, B(a)P transactivated the Ah-receptor in 
COS7-cells, but no further activation was shown in co-exposure to B(a)P and PFAS, presumably 
due to cytotoxic concentrations. The experiments performed in this master’s thesis have 
accentuated that mixture effects is a field that must be explored further, as there are 
indications that combinations of B(a)P and PFAS could indeed give rise to responses beyond 
additive effects. The results from this thesis provide additional information that enhances the 
importance of integrating mixture effects into the toxicity testing and risk assessment of 





Abcb4  ATP-binding cassette B4 (multidrug resistance protein) 
AhR  Aryl hydrocarbon receptor 
acly  APT Citrate Lyase 
acox1  Acyl-CoA oxidase 1 
ANOVA Analysis of variance 
Arnt  Aryl Hydrocarbon Receptor Nuclear Translocator   
B(a)P  Benzo(a)pyrene 
BNF  Beta-naphthoflavone 
cDNA  Complementary DNA 
CFDA-AM 5-carboxyfluorescein diacetate acetoxymethyl ester 
CYP   Cytochrome P450 
cyp1a  Cytochrome P450 1A 
DDT  Dichlorodiphenyltrichloroethane 
DEHP  Bis(2-ethylhexyl)-phthalate  
DMSO  Dimethyl sulfoxide 
DMEM  Dulbecco’s Modified Eagle’s Medium 
DNA  Deoxyribonucleic acid 
EC50  50% of maximal effective concentration  
EDTA  Ethylenediaminetetraacetic acid 
EE2  Ethynylestradiol 
EFSA  European Food Safety Authority 
EGTA  Ethylene glycol-bis(2-aminoethylether)-N,N,N’,N’-tetraacetic acid 
FICZ  6-formylindolo[3,2-b]carbazole 
LRA  Luciferase Reporter Gene Assay 
MTT  3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide 
NRT No reverse transcriptase 
NTC No template control 




PAH  Polycyclic aromatic hydrocarbon 
PBS  Phosphate-Buffered Saline 
PCB126 Polychlorinated Biphenyl 126 (3,3',4,4',5-pentachlorobiphenyl) 
PCLS  Precision cut liver slices 
PCR  Polymerase chain reaction 
POP  Persistent organic pollutant 
PFAS  Perfluoroalkyl substances 
PFOA  Perfluorooctanoic acid 
PFOS  Perfluorooctane sulfonic acid 
PFNA  Perfluorononanoic acid 
PMSF  Phenylmethylsulfonyl fluoride 
Ppara  Peroxisome proliferator-activated receptor alpha 
qPCR  Quantitative real time polymerase chain reaction 
REACH The European Regulation on Registration, Evaluation, Authorisaion and 
Restriction of Chemicals 
RNA  Ribonucleic acid 
Rpm  Revolutions per minute 
RT  Room temperature 
SEM  Standard error of mean 
TCDD  2,3,7,8-Tetrachlorodibenzo-p-dioxin 
TBE  Tris-Borate-EDTA 
TWI  Tolerable weekly intake 
XRE  Xenobiotic response element 
 
 
In this thesis, proteins are given in capital letters, gene names are written in italics, in accordance 






 BACKGROUND  
Environmental contaminants are chemicals that are released into the environment either 
deliberately or unintended, and usually as a result of human activities. Examples are pesticides, 
industrial biproducts, waste materials from production and refinement of oil, and effluents 
from waste discharges. Once released into the environment, these compounds can spread via 
air, rivers, and ocean currents. An important group of environmental contaminants is referred 
to as persistent organic pollutants (POPs). These compounds originate from anthropogenic 
activities and are characterized by their stability and their persistence in the environment. Thus, 
a central property these compounds share is the ability to bioaccumulate within an organism, 
and further biomagnify up the food chain. To be defined as a POP, the compound must be 
persistent, bioaccumulative, toxic, and be subjected to long-range transport (WHO | Persistent 
Organic Pollutants (POPs), n.d.). Examples of POPs are chlordane, 
dichlorodiphenyltrichloroethane (DDT) and polychlorinated biphenyls (PCBs). These 
compounds are all listed in the Stockholm Convention on POPs. This is a convention that was 
put forth for signatories to identify and manage this class of contaminants, and the parties of 
the convention have agreed to reduce or, if possible, eliminate the manufacture, use, and 
import of these POPs to limit the release into the environment (Landis et al., 2018)  
 POLYCYCLIC AROMATIC HYDROCARBONS (PAHS) 
Polycyclic aromatic hydrocarbons (PAHs) comprise a group of organic, lipophilic compounds, 
consisting of aromatic carbon ring structures. They occur naturally in crude oil, and are central 
elements in creosote, tar, and asphalt. They were identified as carcinogens early on, and 
experiments performed already in 1963 showed that exposure to PAHs lead to formation of 
cancer cells (Aune, 2007). PAHs are released to the environment mainly through incomplete 
combustion of organic materials, and there are both natural and anthropogenic sources. 
Generation of power using fossil fuel and burning of waste are two examples of man-made 
emissions, while volcanic activity and forest fires are natural sources. Because of this, PAHs are 
ubiquitous within the environment. In most organisms, these compounds are metabolised 





genetic material and form DNA-adducts, and the biological half-life varies among different 
organisms (e.g. around 24 hours for humans, and 2-3 weeks in blue mussels) (Aune, 2007). The 
most studied PAH is benzo(a)pyrene (B(a)P), and one of the reasons is the broad toxicological 
properties that this compound inhabits. It is known to induce Cyp1a activity through activation 
of the aryl hydrocarbon receptor (Ahr), and Ahr-activation is therefore a commonly used 
biomarker for exposure. In this thesis, B(a)P will be used in co-exposures as a known agonist of 
Ahr. B(a)P itself is one of the xenobiotics that are transformed by P450-enzymes and will 
therefore be able to affect its own metabolism through activation of the Ah-receptor (Mao et 
al., 2018) .   
 PERFLUOROALKYL SUBSTANCES (PFAS) 
Per- and polyfluoroalkyl substances (PFAS) are a group of organic, fluorinated compounds that 
are used both in industry and consumer products. There are over 5000 PFAS congeners on the 
commercial market (Miljødirektoratet, 2019) that are used in various applications, including 
water-resistant fabrics, food packaging, paint, firefighting foams, as non-stick surfactants in 
cookware, and more. Perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) 
are two of the PFAS congeners that have been most widely used. PFAS compounds are stable 
and extremely persistent in nature due to the high energies of the carbon-fluorine covalent 
bonds. Because of the slow decay, they will remain in the environment for long periods and 
have therefore been referred to as “forever chemicals” (Allen, 2018; Gibbens, 2020). This 
property, along with the widespread use, gives these chemicals extended potential for 
exposure, and therefore, PFAS represent one of the more contemporary groups of chemicals 
of environmental concern. 
PFASs are able to bind to blood proteins in vertebrates and accumulate mainly in the liver and 
kidney (Galatius et al., 2013). There are several reported effects of PFAS, and some of them are 
related to immunotoxicity (Grandjean et al., 2012), reproductive toxicity (Lau et al., 2003; 
Luebker et al., 2005), and effects on energy metabolism (Berthiaume & Wallace, 2002). As they 
are amphiphilic, the PFAS tend to accumulate within living organisms and high levels have been 
found in marine mammals and predators on top of the food chain, such as seals and dolphins 
(Galatius et al., 2013; Kannan et al., 2001). The PFAS compounds can be transported over long 





(Landis et al., 2018). Accordingly, PFAS have been found in arctic waters and species, such as 
polar bear (Ursus maritimus) and polar cod (Boreogadus saida) (Kannan et al., 2001; 
Perfluorinated Alkylated Substances, Brominated Flame Retardants and Chlorinated Paraffins 
in the Norwegian Environment - Screening 2013, n.d.). Several monitoring studies along the 
Norwegian coastline have shown that several PFAS congeners are present in sediments, runoff 
water, as well as in fish tissues, including cod liver samples (Kartlegging av utvalgte nye 
organiske miljøgifter 2004, 2005; Perfluorinated Alkylated Substances, Brominated Flame 
Retardants and Chlorinated Paraffins in the Norwegian Environment - Screening 2013, n.d.; 
Valdersnes et al., 2017). PFOS and PFOA are shown to be the most ubiquitous congeners in 
biota, and they are also the most studied PFAS molecules. In addition, PFOS is one of the 
chemicals classified as a POP in the Stockholm Convention on Persistent Organic Pollutants, and 
all production, import, export and sale of merchandise containing PFOS and PFOS-related 
compounds were banned in 2007 (Begrensningsdirektivet - PFOS, 2006). 
1.3.1 PFAS TODAY  
Since the production of PFAS compounds started over half a century ago, there has been a lack 
of regulation regarding manufacture and use of these substances. One example of industrial 
release of PFAS into the environment is linked to a paper-factory’s 50-year long history of 
discharge of such compounds, which were used in the production of various paper wrappings. 
The factory was located along the river Randselva that empties into Tyrifjorden, Norway. 
Tyrifjorden serves as a source of drinking water, and a screening of 53 different PFAS congeners 
performed by the Norwegian Environment Agency showed elevated levels of PFAS in sediments 
throughout the river and fjord (Tyrifjorden, 2019). The skiing industry has also been a 
contributor of PFAS-exposure and release of PFASs into the environment. Through the article 
series “Glidens pris”, the Norwegian magazine Dagbladet shed light on poor working 
conditions, high mortality-, and cancer rates amongst workers in an Italian factory producing 
ski wax for the Norwegian company Swix. A cohort study of workers that most likely had been 
exposed to PFAS and exhibited elevated serum concentrations of PFOA, showed a higher risk 
of overall mortality, diabetes, liver cancer, and liver cirrhosis (Girardi & Merler, 2017). As a part 
of the article series, Norwegians applying wax to skis on an amateur level also got the PFAS-
levels in their blood tested, and PFOA-levels varied between 8 and 36 ng/ml compared to an 





PFAS have also been found in soil-samples, bank vole (Myodes glareolus) and earthworm 
(Eisenia fetida) in a skiing area in Granåsen, Norway, and the PFAS patterns in the soil resembled 
the patterns found in commonly used ski wax samples, indicating that this is indeed an 
important source of environmental contamination (Grønnestad et al., 2019).  
As food is also a source of PFAS exposure for humans, the European Food Safety Authority 
(EFSA) set a new safety threshold for the main PFAS that accumulate in humans in September 
2020. Tolerably weekly intake (TWI) of PFAS congeners as a group is now lowered to 4.4 ng per 
kilogram bodyweight (EFSA, 2020). From July 2020, EU banned the production and sale of 
chemicals and products containing more PFOA than 0.025 ng/kg product, and this also includes 
around 100 other compounds that could be precursors of PFOA (Skadelig fluorstoff forbudt - 
Miljødirektoratet, n.d.). From the season 2021/2022, the International Ski Federation (FIS) has 
also decided to ban the use of fluorinated compounds in competitions.  (Aftenposten, 2020; 
Decisions of the FIS Council Meeting in Constance (GER) Autumn 2019, 2019). It is important 
that one regulated PFAS compound is not simply replaced by another congener with similar or 
more harmful effects. Since there are many similarities between different PFAS molecules, it is 
suggested that these compounds should be managed as a class, such as for example 
organophosphate pesticides already are, to ensure an efficient approach to reduce adverse 
effects on humans and environmental health (Kwiatkowski et al., 2020).  
 MIXTURE EFFECTS 
Toxicity testing has traditionally been performed on one compound at a time, but the scenarios 
in which organisms are exposed are more complex than that. Different xenobiotics are present 
in mixtures, and seldom one by one. These mixtures might give rise to so-called “cocktail 
effects”, where the combined response is not simply the sum of the effects induced by each 
toxicant alone. The combined effects may be higher (synergistic or potentiating), or they may 
be less than the effects produced by the compounds separately (antagonistic) (Bizarro et al., 
2016; Silkworth et al., 1993). As mentioned, benzo(a)pyrene is a well-studied compound, and 
so are some of the most used PFAS congeners as well, but the combinations of these 
compounds and the mixture effects they could give rise to is a less explored field. Previous 
research has suggested that PFAS can modulate the uptake and toxicity of other chemicals, and 





interfering with cellular efflux transporter ATP-binding cassette B4 (Abcb4) proteins (Keiter et 
al., 2016). Notably, mixture-specific induction of the P450 system has been shown in zebrafish 
(Danio rerio) after exposure to polychlorinated biphenyl 126 (PCB126) and PFAS (Blanc et al., 
2017), and combinations of PAHs and PFAS have shown to increase lipid catabolism in Atlantic 
cod by affecting lipid degradation pathways in liver (Dale et al., 2020). It is therefore important 
to assess how different compounds interact in relevant mixtures, in addition to the traditional 
toxicity analyses of single substances.  
 
Figure 1: Complex exposure scenarios to environmental contaminants might give rise to so-called cocktail effects. 
1.4.1 THE ARYL HYDROCARBON RECEPTOR 
The Aryl hydrocarbon receptor (Ahr) is a xenosensor that mediates cellular responses to 
environmental pollutants. It belongs to the helix-loop-helix family of dimeric transcription 
factors, and unliganded, the receptor is located in the cytoplasm of the cell in a protein complex 
with two HSP90 proteins, a cochaperone protein (p23), and Ahr-interacting protein (AIP) (Avilla 
et al., 2020). The binding of a ligand allows the ligand-receptor-complex to dissociate from the 
chaperones and translocate into the nucleus of the cell (Larigot et al., 2018). Inside the nucleus, 
the ligand-receptor complex heterodimerizes with the aryl hydrocarbon receptor nuclear 
translocator (Arnt), and Ahr-Arnt is a competent DNA-binding heterodimer. The dimer binds to 
xenobiotic response elements (XREs) upstream of Ahr-target genes and induces the 
transcription of genes encoding enzymes that are involved in the biotransformation of 





is also induced by Ahr, and AhRR will bind to Arnt, competing with the dimerization to Ahr and 
forming a negative feedback regulation of Ahr transcriptional activity. The CYP1 metabolism of 
ligands and the interaction of AhRR with Arnt will prohibit further Ahr-Arnt dimerization (Avilla 
et al., 2020). 
 
Figure 2: Ahr signalling pathway and regulatory functions. Created in Biorender.com, redrawn after (Larigot et al., 
2018) 
Some well-known Ahr agonists are B(a)P, beta-naphthoflavone (BNF), PCB126, and 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD), where the latter is the most potent exogenous ligand. 
Experiments performed on mice have shown that B(a)P-exposure induced cancer tumours in 
Ahr-positive mice, but that no tumours were formed in Ahr-deficient mice. This indicates that 
the biotransformation caused by activation of the Ah-receptor and mediated through Cyp1a is 
central in giving B(a)P its cancer forming potential (Shimizu et al., 2000). 
1.4.2 PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) 
A similar family of xenobiotic-responsive transcription factors are the peroxisome proliferator-





for peroxisome proliferators, which are xenobiotics that can increase the size and number of 
peroxisomes within liver cells (Issemann & Green, 1990). PPAR alpha (Pparα) is one of the 
PPARs that regulates fatty acid oxidation through induction of the gene Acyl-coA oxidase 1 
(acox1), which is a key enzyme in the first stage of β-oxidation. ATP citrate lyase (acly) is also 
an important PPARα target gene as it codes for the enzyme that function as a cross-link 
between the glycolysis and the fatty acid synthesis pathway. PPARα has shown to play a role in 
the cancer development in rodents exposed to the phthalate bis(2-ethylhexyl)-phthalate 
(DEHP) as PPARα knockout mice are resistant to DEHP-induced tumours  (Burcham, 2014). 
PFOS, PFOA and perfluorononanoic acid (PFNA) have previously shown to modulate the activity 
of mouse, human and cod PPARα and (Behr et al., 2020; Söderström, 2017; Takacs & Abbott, 
2007). 
 ATLANTIC COD  
The term “In cod we trust” might have occurred as a misprint on American coins but made 
perfect sense to our Norwegian ancestors. For thousands of years, the cod has been a central 
part of living and frankly the basis of existence in Norway. It has been of great importance to 
the Norwegian economy and identity, and was used to trade for other goods, and as a currency 
in payment for tax or rent (Jenssen, 2012). The cod is still the “white gold” of the North East 
Atlantic, and the most valuable species within the fisheries sector in Norway.  In 2019, amounts 
worth a total of 10.1 billion NOK were exported. This was a 7% increase in value since 2018 
despite a 8% decrease in volume (Sjømateksport for 107,3 milliarder kroner i 2019, 2020). In 
addition to being an important food source, the cod’s widespread distribution makes it 
vulnerable to effluents of anthropogenic sources, and hence it is also used as an indicator 
species for monitoring the presence of pollutants in the environment. Cod is included in the 
Convention for the Protection of the Marine Environment of the North-East Atlantic (the OSPAR 
convention) List of threatened and/or declining species or habitats. The Atlantic cod belongs to 
the family Gadidae and is widely spread throughout the North Atlantic and the Baltic ocean 
(Figure 3).  
Cod resides both in the shoreline and the continental shelf, and although it is considered a 
demersal fish it inhabits the pelagic ocean at different conditions and phases of its life cycle 





Along the coast of Norway, we mainly separate between three main types of Atlantic cod: the 
coastal cod, the fjord cod and the “skrei”, which migrates from the Barents Sea and spawns 
along the Norwegian coast.  
 
Figure 3: Distribution of Atlantic cod (Gadus morhua). Map: (FAO Fisheries & Aquaculture - Species Fact Sheets - 
Gadus Morhua (Linnaeus, 1758), n.d.) 
The genome of the Atlantic cod was recently sequenced and annotated (Star et al., 2011), and 
this has made it possible to perform large scale toxicogenomic studies on this species. It has 
been frequently used as a model organism (Bizarro et al., 2016; Dale et al., 2020; Meier et al., 
2007; Sturve et al., 2006). The cod has two gmAhr-encoding genes, Ahr1a and Ahr2a, which 
demonstrate tissue-specific expression profiles and differences in ligand binding affinities 
(Aranguren-Abadía et al., 2020). The liver is a central target organ for contaminants as it plays 
a major role in detoxification of xenobiotics, and it may have a higher susceptibility to 
accumulation of lipophilic contaminants as the cod has a very fatty liver where the hepatocytes 
contain several large lipid droplets (Fujita et al., 1986).  
 PCLS AS AN EX VIVO MODELLING SYSTEM 
Cell culture, such as cell lines or primary cells, is an in vitro model system that is widely used, 
and in line with the 3R principles (Tannenbaum & Bennett, 2015) by considerably reducing the 
use of animals in scientific experiments. It is a convenient methodology to use as most cell 





quantified. However, some limitations exist. For instance, due to cell differentiation and 
mutagenic events as a result of cultivation, isolated cell systems have shown limited ability to 
predict toxicity in vivo  (Segner, 1998).  Also, the unique hepatocyte morphology in Atlantic cod 
makes the isolation techniques of primary cells less efficient than with other species. Precision 
cut liver slices (PCLS) is another model system that also has been applied in several toxicological 
studies (Bizarro et al., 2016; Du et al., 2016; Eide et al., 2014). As with cell cultures, this method 
creates the opportunity to conduct experiments in a lab environment reducing the amounts of 
test individuals needed, and at the same time provide highly relevant results, as it is a versatile 
ex vivo model where the distribution of the cells maintain the 3-dimensional tissue structure as 
found in vivo. PCLS have shown to give a closer prediction of in vivo toxicity than cell cultures 
(Elferink et al., 2008). Furthermore, in this system the biotransformation of compounds could 
occur, and through activation of the P450 system, the compounds could affect their own 
metabolism. In 1985 Smith et al. published the first paper on isolation and maintenance of PCLS 
and use in toxicology (Davies, 2012). In the later years, different variations of the technique 
have been presented, and applied to numerous other species, including Atlantic cod (Gadus 
morhua) (Eide et al., 2014). As in most other vertebrates, the detoxification of xenobiotics 
occurs mainly in the liver of Atlantic cod. Therefore, cod liver slices were used to assess the 
toxicity of the compounds and mixtures used in this thesis. When preparing precision cut liver 
slices, the central part of the cod liver was cut into thin slices using a vibratome and kept in 
culture medium. The slices must be thin enough to make sufficient diffusion of oxygen and 
nutrients possible, and given the right conditions, Atlantic cod PCLS are viable in culture for at 
least 72 hours (Eide et al., 2014).  
 THE LUCIFERASE REPORTER GENE ASSAY 
The Luciferase Reporter Gene Assay (LRA) is a commonly used in vitro system for 
characterization of ligand activation of transcription factors, such as Ahr and nuclear receptors, 
and is used to study regulation of gene expression at a transcriptional level. It is a quick and 
sensitive assay that provides quantitative measurements of potencies and efficacies, and it has 
been used to characterize Ahr in various fish species, such as zebrafish , Atlantic cod and 
rainbow trout (Oncorhynchus mykiss) (Abnet et al., 1999; Aranguren-Abadía et al., 2020; 
Hansson & Hahn, 2008). Different variations of the method exist, but in general, a cell line is 





In this thesis, an Ahr/Arnt/XRE based system was used, where COS-7 cells were initially 
transfected with the receptor plasmids (pcDNA3.1_gmAhr2a; pcDNA3.1_gmArnt), a luciferase 
reporter plasmid (pGudLuc6.1), a normalization plasmid (pCMV-β-galactosidase) and empty 
pcDNA3.1/Zeo. Through ligand binding, Ahr will dimerize with Arnt and bind to xenobiotic 
response elements (XRE) that are located in the promoter region upstream of the luciferase 
reporter gene. Binding of the Ahr/Arnt dimer induces the transcription of the reporter gene, 
and luciferase is produced. Figure 4 illustrates schematically how this happens.  
 
Figure 4: In vitro reporter gene system for ligand binding and transactivation. 
After lysis of the cells, D-luciferin is added to the wells and the luciferase enzyme will catalyse 
the reaction illustrated in Figure 5. Oxyluciferin is a luminescent compound, and nearly all the 
energy put into the reaction is rapidly converted to light as oxyluciferin falls back to its ground 
state. The measured luminescence will reflect the receptor activation.  
 









This study is considered a continuation of previous work done in our group by (Dale et al., 2020) 
where Atlantic cod was exposed in vivo to mixtures of 6 different PAHs and 4 different PFASs in 
either a low dose considered environmentally relevant (1x), or a high dose (20x). Fish were 
exposed to low or high doses of PAHs and PFAS either separately or combined to study potential 
mixture effects between the two classes of compounds. Few mixture effects were revealed in 
this experiment, but the results showed that the high dose exposure to PFAS congeners 
influenced peroxisomal and mitochondrial fatty acid catabolic pathways, as several PPARα 
target genes and important enzymes in β-oxidation were upregulated.  
The aim of this master’s thesis is to characterize toxicological effects in Atlantic cod after co-
exposure to three relevant PFAS compounds and benzo(a)pyrene, focusing on changes in gene 
expression levels and Ahr activation.  Two model systems are used, precision cut liver slices and 
a luciferase reporter gene system using COS-7 cells. By studying alterations in gene expression, 
modulation of the energy metabolism and the biotransformation of xenobiotics will be 
especially targeted. Three of the PFAS compounds used by (Dale et al., 2020) in addition to a 
PFAS mixture was selected, and exposure to the PFAS compounds was done both separately 
and in combination with benzo(a)pyrene to characterize potential mixture effects between 
PFAS and PAHs. The following questions were asked:  
▪ Could PFASs alter the energy metabolism and the biotransformation of xenobiotics in 
Atlantic cod?  
▪ Could PFASs modulate the toxicity of B(a)P in Atlantic cod?  









2 MATERIALS  
 ATLANTIC COD (GADUS MORHUA) 
The Atlantic cod used in this work were hatched during the spring 2018 at Havbruksstasjonen i 
Tromsø AS (Tromsø, Norway) and transported to Bergen in August the same year. The cod were 
kept at the Industrial and Aquatic Laboratory (ILAB, Bergen, Norway) in 500L tanks in natural 
seawater at 8-10°C at a 12/12 h light cycle regime, and fed ad libitum with commercial feed, 
Amber Neptun (Skretting, Stavanger, Norway).  
 
 CHEMICALS AND REAGENTS 
Table 1: List of chemicals and reagents used in the thesis 
Chemical/reagent Supplier / Product number 
2-log ladder (0.1 – 10 kb) New England Biolabs / N3200s 
5-carboxyfluorescein diacetate acetoxymethyl 
ester (CFDA-AM) 
Thermo Fisher Scientific / C1354 
β-mercaptoethanol  Aldrich / M6250 
 Adenosine triphosphate (ATP)  Sigma / A2383 
Agarose Sigma / 2A9538 
Ampicillin sodium salt  Sigma-Aldrich / 69-52-3 
BlueJuice™Gel loading buffer (10 X) ThermoFisher / 10816-015 
Boric acid Merck / A9647 
Bovine serum albumin (BSA) Sigma / A4503 




CHAPS Appli-Chem / A1099 
Chloroform  Sigma-Aldrich / 67-66-3 
Coenzyme A Fisher Scientific / 18439-24-2  
D-Luciferin (Firefly) Bio-Synth / L-8200 
Dimethyl sulfoxide (DMSO) Sigma / D8418 
Disodium hydrogen phosphate Na2HPO4 Sigma / 30435 
DL-Dithiothreitol (DTT) Sigma / D0632 
Dulbecco’s Modified Eagle’s Medium – high 
glucose (w/ phenol red) 
Sigma / D5671 
Dulbecco’s Modified Eagle’s Medium - high 
glucose (w/o phenol red) 
Sigma / D1145 
Erythrosine B Sigma-Aldrich 
Ethanol Sigma / 32221 
Ethylene diamine tetraacetic acid (EDTA) Merck / 108418 
Ethylene glycol tetraacetic acid (EGTA) Sigma / E3889 
Foetal bovine serum (FBS) Sigma / F7524 
Formamide Sigma / F9037 
Galactose Sigma-Aldrich / G0625 
GelRed Biotium / 41003 
Glycerol Sigma / G5516 




L-α-phosphatidylcholine Sigma / P3644 
Leibowitz-15 medium (-phenol red + L-
glutamine) 
TermoFisher / 21083- 027 
L-glutamine Sigma / G7513 
Magnesium carbonate hydroxide 
pentahydrate Mg(CO3)4Mg(OH)·5H2O 
Sigma-Aldrich / 56378-72-4  
Magnesium chloride MgCl2 Merck 
Magnesium chloride hexahydrate MgCl2·6H2O Sigma-Aldrich / M9272 
Magnesium sulfate heptahydrate 
MgSO4·7H2O 
Sigma-Aldrich / 63140 
OptiMEM w/glutamax Life Technologies / 31985- 062 
Ortho-Nitrophenyl-β-galactoside (ONPG) Sigma / N1127 
Penicilin-streptomycin-amphotericin (1%) Sigma-Aldrich 
Penicillin-streptomycin (1000U) Sigma / P4458 
Phenylmethylsulfonyl fluoride (PMSF) Sigma / P7626 
Phosphate buffered saline (PBS) 10X Sigma / P5493 
Potassium chloride KCl Sigma / P9541 
Potassium dihydrogen phosphate KH2PO4 Merck 
Resazurin Sigma-Aldrich 
Sodium bicarbonate NaHCO3 Merck 




Sodium phosphate dibasic dihydrate 
Na2HPO4·2H2O   
Sigma-Aldrich 
Sodium pyruvate Sigma / S8636 
TransIT® LT1 Mirus / MIR 2300 
Tricine Sigma / T0377 
TriReagent Sigma / T9424 
Tris HCl (pH 7.8) Merck 
Triton® X100  Sigma-Aldrich / T4258 





















Table 2: Ligands used in PCLS- and COS-7 cell exposure 
 
 
































Table 3: Commercial kits used in PCLS 
Kit Description Supplier/product number 
Cytotoxicity Detection kit (LDH) Cytotoxicity testing (PCLS) Roche / 11644793001 
iScript™ cDNA Synthesis kit  Reverse transcription BioRad/1708891 
Lightcycler® 480 SYBR Green Quantitative real-time PCR Roche / 04887352001 
 
Table 4: Commercial kits used in Luciferase reporter gene assay 
Kit Description Supplier/product number 
NucleoBond® Xtra Midi plasmid 
purification kit 







2.4.1 PRECISION CUT LIVER SLICES 
Table 5: PCLS-buffer 






pH adjusted to 8.4, volume brought to 1 L with deionized water, solution sterile filtered and 
stored at 4°C 
 
Table 6: Culture medium used for PCLS 
Component Volume (mL) 
Leibowitz-15 medium (÷ phenol red, + L-glutamine) 44.5 
Charcoal-stripped + heat-inactivated FBS  5.0 









Table 7: Tris-borate-EDTA (TBE) buffer (5X) 
Component Concentration (M) 
Tris HCl 0.45 
Boric acid 0.45 
Ethylenediamine tetraacetic acid (EDTA) 0.01 
Deionized water - 
 
Table 8: Preparation of 0.75% agarose gel 
Component Amount   
Agarose 1.125 g 
0.5 X Tris borate EDTA (TBE) buffer 150 mL 












2.4.2 LUCIFERASE REPORTER GENE ASSAY 
Table 9: Culture medium used for cultivation of COS-7 cells (DMEM w/10% FBS) 
Component Volume (mL) 
Dulbecco's modified Eagle medium (DMEM) 500 
Foetal Bovine Serum (FBS) 50 
L-glutamine 10 
Sodium pyruvate 5.0 
Penicillin-streptomycin (10 000U)  5.0 
During ligand exposure, DMEM w/o phenol red and super stripped FBS was used. 
 
Table 10: Composition of DMEM-transfection medium 
Component Volume per well (µl) 
Plasmid mixture 0.1 
OptiMEM w/glutamax 9.0 
TransIT LT1 0.2 









Table11: Cell lysis base buffer (1.05X) for luciferase reporter gene assay 
Component Concentration 






Table 12: β-galactosidase base buffer (10 X, pH 7.2) for luciferase reporter gene assay 






Table 13: Luciferase base buffer (4 X, pH 7.8) for luciferase reporter gene assay 
Component Concentration (mM) 
Tricine 80 






Table 14: Lysis buffer 
Component Concentration 
Cell lysis base buffer (1.05 X) (Table 11) 1 X 
EGTA (100 mM) 4.0 Mm 
DTT (1000 mM) 1.0 mM 
MgCl2 (500 mM) 8.0 mM 
PMSF (250 mM) 0.4 mM 
 
Table 15: β-galactosidase reaction buffer 
Component Concentration 
β-gal base buffer (1 X) (Table 12) 1.0 X 
β-mercaptoethanol (14.2 M) 52.9 M 












Table 16: Luciferase reaction buffer 
Component Concentration 
Luciferase base buffer (4 X, pH 7.8) (Table 13)  1 X 
Deionized H2O - 
DTT (1000 mM) 5 mM 
ATP (100 mM) 0.5 mM 
Coenzyme A * 0.2 mM 
D-luciferin (10 mM) * 0.5 mM 
* Added just before use 
Table 17: L15/ex medium 
Component Volume (mL) 
Solution A (Table 18) 34 
Solution B (Table 19) 6.0 
Solution C (Table 20) 17 
Galactose (90 mg/l) 5.0 
Sodium Pyruvate (110 mM) 2.5 








Table 18: L15-solution A 





Volume brought to 600mL with deionized water, solution autoclaved and stored in RT. 
 
Table 19: L15-solution B 
Component Mass (g) 
CaCl2 1.4 
Volume brought to 100mL with deionized water, solution autoclaved and stored in RT. 
Table 20: L15-solution C 
Component Mass (g) 
Na2HPO4 1.9 
KH2PO4 0.6 








Table 21: Resazurin-CFDA-AM solution 
Component Volume (µL) 
Resazurin (0.15 mg/ml) 20 
CFDA-AM (4 Mm) 0.1 
L15/ex medium (Table 17)  79.9 
 
 
 PRIMERS, PLASMIDS & CELL LINES 
Table 22: Primers used in PCLS 























Table 23: Plasmids used in luciferase reporter gene assay 
Plasmid Description 
pcDNA3.1_gmAhr2a 
Eukaryote expression plasmid encoding cod Ahr2, receptor 
plasmid) 
pcDNA3.1_gmArnt Eukaryote expression plasmid encoding cod Arnt 
pCMV-β-galactosidase 
Eukaryote expression plasmid encoding β-galactosidase, 
LRA transfection control plasmid 
pGudLuc6.1 
Eukaryote expression plasmid encoding firefly luciferase, 
LRA reporter plasmid 
pcDNA3.1/Zeo Eukaryote expression vector plasmid, empty 
 
Table 24: Cell lines used in luciferase reporter gene assay 
Cell line Description Supplier / product number 
StrataClone Solo Pack 
competent cells     
Prokaryote cloning (E. coli)   Agilent / 240205 
COS-7 cells    
Eukaryote kidney cell (African 










Table 25: Instruments used 
Instrument Application Supplier 
CFX96™ RealTime PCR System 
C1000™ Thermal Cycler         
qPCR BioRad 
ChemiDocTM XRS+ System               Gel scan               BioRad 
DOPPIO Thermal Cycler                PCR Thermo Cycler                  VWR 
EnSpire 2300 Multilabel Reader              Plate reader              PerkinElmer 




Xenox / D-54343 
HS 501 Digital                   Shaker IKA-Werke 
Leica DMBL Leica Microsystems             Microscope LEICA 
Leica VT1200 S vibrating blade 
vibratome          
Vibratome LEICA 
Mini Vortex 230V Mixer VWR 
Nanodrop One  Spectrophotometer Thermo Scientific 
New BrunswickTM Galaxy® 170 R                   CO2-incubator Eppendorf 
PowerPac™ HC High-current power supply         BioRad 
Ultrospec 10 Cell density meter Amersham Biosciences 





Table 26: Software used 
Software Application Supplier 
BioRad CFX Manager 3.1 Analysis of qPCR data BioRad 
Biorender.com Figure  
EnSpire Manager Operation of plate reader PerkinElmer 
Excel (2009)             Data treatment Microsoft 
ImageLab Agarose gel visualization BIO RAD 

















 PRECISION CUT LIVER SLICES 
3.1.1 EXPERIMENTAL DESIGN 
In the first part of the thesis, precision cut liver slices (PCLS) were prepared and exposed to the 
compounds of interest for 48 hours. The slices were then harvested, and extraction of RNA was 
done to prepare complementary DNA (cDNA). The cDNA was used in quantitative real-time PCR 
(qPCR) to measure the expression of the genes of interest. To assess the cell viability, a 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay was also conducted (Figure 
6).  
 
Figure 6: Flow chart of the process from collecting the cod liver to running the qPCR analyses and cell viability assay 
(MTT) 
 
3.1.2 EXPERIMENTAL DESIGN 
The compounds studied in this thesis were the perfluoroalkyl substances (PFAS) PFOS, PFOA 
and PFNA, in addition to the PAH compound B(a)P. All compounds were dissolved in 100% 




solutions were added to 2 mL of culture medium, all exposures would have a 0.1% final DMSO 
concentration, and 0.1% DMSO was therefore used as solvent control. Exposure to B(a)P alone 
was also done to demonstrate the compound’s capability of activating cyp1a gene expression. 
Three concentrations of B(a)P were used, 0.1, 1.0 and 10 µM, and four replicate exposures of 
each concentration were carried out (n=4 fish). An LDH assay was conducted to assess the 
cytotoxicity of B(a)P before choosing the fixed concentration for the co-exposures. This work is 
not described here. 
Two experiments were performed using PCLS. In Experiment 1, the liver slices were exposed to 
PFOS, PFOA, PFNA, or a PFAS-mix, in increasing concentrations in addition to a solvent control. 
In Experiment 2, the PCLS were exposed to the same PFAS-compounds, but in combination with 
B(a)P at a fixed concentration. The concentrations given for the PFAS-mix represent ΣPFAS, 
which means that the 10 µM exposure consists of 3.33 µM PFOS, 3.33 µM PFOA and 3.33 µM 
PFNA. This also applies to the 50 µM and 100 µM PFAS-mixtures.  
Experiment 1 
The PCLS were exposed to three different concentrations (10, 50 and 100 µM) of each PFAS 
congeners, as well as the mix containing all three PFASs as shown in Table 27. Four replicates 
of each exposure were carried out using n=4 fish (n=6 for B(a)P + PFAS-mixture).  
Table 27: Overview of test compounds and concentrations used in the single compound and PFAS-mixture 
exposures of the PCLS (Experiment 1). 
Compound (µM) Exposures 
 Solvent control  PFOS PFOA PFNA PFAS-mix 
DMSO (0.1%) x X x X X 
PFOS (10, 50, 100)  X   X 
PFOA (10, 50, 100)   x  X 





Experiment 2:  
In Experiment 2, the liver slices were exposed to the same PFAS-concentrations as used in 
Experiment 1, and in addition in combination with a fixed B(a)P-concentration of 1 µM (Table 
28). 
Table 28: Overview of test compounds and concentrations used in combined exposures of the PCLS (Experiment 2).  
Compound (µM) Exposures 
 Solvent control  B(a)P B(a)P + PFOS B(a)P + PFOA B(a)P + PFNA 
B(a)P + 
PFAS-mix 
DMSO (0.1%) x x x x x x 
BaP (1.0)  x x x x x 
PFOS (10, 50, 100)   x   x 
PFOA (10, 50, 100)    x  x 
PFNA (10, 50, 100)     x x 
 
3.1.3 PREPARATION OF PRECISION CUT LIVER SLICES 
Juvenile fish of both sexes were used for the experiments, in total 11 male and 9 female fish. 
To obtain a semi-sterile work environment, work benches and all equipment were washed 
using 70% ethanol before the experiments began. The PCLS buffer was sterile filtered (0.2 µm) 
into an autoclaved glass flask and kept at 4°C (for up to two weeks). Each individual cod was 
euthanized with a blow to the head before length and weight were registered, --and the fish 
opened on the ventral side, from the gills to the anus using a scalpel. The sex of the fish was 
recorded, before the liver was dissected free, weighed, and placed in PCLS-buffer. The liver was 
kept on ice throughout the procedure to reduce degradation of liver cells. Cubes measuring 
3x2x1-2 cm were prepared from the central part of the liver using a Feather® cutting blade and 
transferred to culture medium (Table 6). The cubes were then glued onto a directional 




surrounded with ice. A vibratome (Leica VT1200 S vibrating blade vibratome, LEICA biosystems) 
was used to cut 250 µm thick tissue slices, which were further sliced into squares measuring 
approximately 5x5 mm. Prepared slices and squares were kept in culture medium until 
sufficient material needed for conducting the exposure experiments was obtained. Four 
squares were transferred to each well of a 12-well plate containing 2 ml culture medium, and 
equilibrated for 2 hours on 50 revolutions per minute (rpm) shaking at 10°C.  
3.1.4 EXPOSURE AND HARVESTING OF PCLS 
After the equilibration period, the liver slices were exposed to the compounds of interest by 
adding the compounds (2 µl of 1000x exposure concentrations) directly into the wells. To avoid 
direct exposure of the stock solutions to the hepatic cells, the plate was tipped, and the liver 
slices moved to one side of the well as the test compound was added to the opposite side. The 
compounds were mixed thoroughly into the medium using a pipette before the plate was 
levelled and the slices moved away from the wall of the well. Exposures were performed for 48 
hours at 50 rpm shaking at 10°C. After 48 hours of exposure, the cells were harvested. Using 
tweezers, the liver slices were transferred to 1.5 mL microcentrifuge tubes, weighed and snap-
frozen by being placed directly in liquid nitrogen, and subsequently stored at -80°C.  
3.1.5 RNA EXTRACTION 
Precision cut liver slices were collected from the -80°C-freezer and placed in liquid nitrogen. 
500 µl trizol (TriReagent Sigma) was added to the frozen tissue in each tube and the samples 
were homogenized using a homogenization tool (Xenox). Additional 500 µl trizol was added, 
and the tubes were flipped a few times and placed on ice. The homogenization tool was rinsed 
with dH2O between samples and washed thoroughly when changing between PCLS exposed to 
different compounds. When all samples were homogenized, they were incubated in room 
temperature (RT) for 5 minutes before 200 µl chloroform was added to each tube. The tubes 
were closed and shaken for approx. 30 seconds before another 5 minutes of incubation in RT. 
They were then centrifuged using a Z216MK microliter centrifuge (Hermle) at 12000 x g for 15 
minutes at 4°C for separating the material into the organic and aqueous phases. From the upper 
aqueous phase, 300 µl was transferred to a new tube using a pipette, and an equal amount 
(300 µl) of 100% isopropanol was added for the RNA to precipitate. The samples were again 




supernatant was removed with a pipette, leaving the RNA-pellet in the tube. To wash the RNA, 
1 ml of 75% ethanol was added, and the tubes were vortexed to make sure the pellets were no 
longer attached to the tube wall. The tubes were centrifuged at 7500 x g at 4°C for 5 minutes, 
the supernatant was removed, and the washing step with 1 ml of 75% ethanol was repeated. 
The supernatant was again removed before the samples were centrifuged for 5 seconds and 
the residues of ethanol removed by pipetting. The samples were left to dry with the lids open 
for approximately 20 minutes in RT, until all the ethanol had evaporated, and the pellets had 
changed colour from white to transparent. The RNA was then dissolved in 50 µl RNase-free 
dH2O and incubated at 60°C for 20 minutes. The tubes were then vortexed and centrifuged 
before the concentration and purity of the RNA was measured using a Nanodrop One 
(Nanodrop-One Thermo Scientific) instrument. 
3.1.6 AGAROSE GEL ELECTROPHORESIS 
Agarose gel electrophoresis was used to assess the integrity of the RNA. First, a 0.75% agarose 
gel solution was prepared as described in Table 7. GelRed was used to visualise the nucleic 
acids, and 0.5 X Tris-borate-EDTA (TBE) buffer (Table 6) was used both in the preparation of the 
gel and as running buffer in the electrophoresis. The samples were prepared by adding 5 µL 
formamide, 1 µL 10x loading buffer (BlueJuice™Gel, ThermoFisher) and 3.5 µL RNA-free H2O to 
0.5 µL RNA-sample. Formamide was added to remove any secondary structures, and the 
samples were further denatured by incubating them at 60°C for 10 minutes before they were 
centrifuged and 10 µl of each sample was loaded into the wells of the gel. A 2log ladder (New 
England Biolabs) was used as molecular weight marker, and the electrophoresis was run at 
100V for 1 hour and 5 minutes. A picture of the gel was obtained using ChemiDocTM XRS+ 
System (BioRad). 
3.1.7 PREPARATION OF cDNA 
The RNA isolated from the PCLS was used to synthesize cDNA for further use as templates in 
polymerase chain reactions. The RNA samples were thawed and diluted in 8-tube PCR-strips to 
give a final concentration of 50 ng/µl. The RNA was then denatured to avoid any secondary 
structures, using a thermocycler (DOPPIO Thermal Cycler, VWR) at 70°C for 5 minutes. Using 
the iScript™ cDNA Synthesis Kit (Bio-Rad), a master-mixture (Table 29) of 5x iScript buffer, 




mixed by pipetting before it was incubated in the thermocycler following the program 
described in Table 30 to produce cDNA. 
Table 29: Components used to synthesise cDNA using iScript™ cDNA Synthesis Kit (BioRad). 
Component Amount 
5x iScript buffer 4.0 µL 
iScript Reverse Transcriptase 1.0 µL 
RNA 1000 ng 
Nuclease free dH2O - 
Total 20 µL 
 
Table 30: Reaction protocol for synthesis of cDNA using iScript™ cDNA Synthesis Kit (BioRad) 
Component Temperature (°C) Time (min.) 
Priming 25 5 
Reverse transcription 46 20 
RT inactivation 95 1 
Hold (optional) 4 Forever 
 
From a mixture of RNA-samples, a “no reverse transcriptase” (NRT) sample was prepared to 
monitor potential DNA contamination. The same procedure as for the RNA samples was 
followed, but with no reverse transcriptase added. A “no template control” (NTC) where the 
RNA-sample was replaced with nuclease-free H2O was also prepared, to monitor background 




3.1.8 GENE EXPRESSION ANALYSES 
To assess the expression of cyp1a, acox1 and acly, qPCR analyses were performed. This is a 
sensitive assay with high accuracy and throughput. The prepared cDNA was collected from the 
freezer and thawed before it was used in qPCR analyses. The cDNA was diluted 1:10 before 5.0 
µl (125ng) was added to the wells of a white qPCR-plate as it is optimized for signal detection 
during real time qPCR. Forward and reverse primers were mixed and diluted to 2 µM before a 
master mix of primers and SYBR Green was made as described in table 31 and added to the 
cDNA in the qPCR-plate. Each sample was added to the plate in triplicates concerning the target 
genes analysed, and duplicates for the reference gene, arp. This gene was used as a reference 
gene in all experiments to normalise differences in gene expression that could arise because of 
the varying cell distribution in PCLS. The components were mixed before the plate was sealed 
with Microseal® ‘B’ Seal (Bio-Rad) and centrifuged at 1200 x g for 2 minutes. The qPCR was run 
in CFX96™ RealTime System C1000™ Thermal Cycler (BioRad) following the protocol described 
in Table 32. 
Table 31: Components used in preparation for qPCR. 
Component Volume (µl) 
cDNA 5.0 
Primer mix (2µM) 5.0 










Table 32: Reaction protocol qPCR analyses using Lightcycler® 480 SYBR Green. 
Component Temperature (°C) Time 
Enzyme activation 95 10 min 








95 10 sec 
72 5 sec  
Hold (optional) 4 Forever 
                 
3.1.9 MTT 
To assess if the concentrations used were cytotoxic to the liver slices, an MTT assay was carried 
out on three replicates per exposure. The MTT assay is a colorimetric assay used to assess cell 
metabolic activity as the water soluble MTT will be transformed into a coloured insoluble 
formazan compound by healthy, living cells. The amount of colour (formazan) produced is 
directly proportional to the number of viable cells. During exposure, a 12-well plate identical to 
the exposure plate was prepared, using cut-offs from the liver slices (  ̴15mg). These liver slices 
were exposed to the same compounds as the other slices for 48 hours. Triton (1%) was used as 
positive control of cytotoxicity. After 48 hours of exposure, each slice was weighed and 
transferred to a new well containing 1 ml cold phosphate buffered saline (PBS) and incubated 
on a shaker at 50 rpm at RT for 5-10 minutes. The PBS was then replaced by 2 ml MTT solution 
(2 mg/ml dissolved in L-15 medium), and the plate was covered in aluminium foil and incubated 
in RT at 50 rpm for 90 minutes.  
After incubation, the MTT solution was replaced by 1 ml cold PBS and incubated at 50 rpm in 




RT at 50 rpm for 20 minutes. Triplicates of 100 µl per sample were transferred to a transparent 
96 well-plate, and the absorbance of the formazan solution was measured at 590 nm using a 
Perkin Elmer Enspire 2300 Multilabel Plate Reader.   
 
 
Figure 7: The reaction happening when MTT solution is added to viable cells. Modified version from (Riss et al., 
2016). 
 
3.1.10 DATA TREATMENT AND STATISTICS 
The cq-values retrieved from the CFX96™ RealTime System C1000™ Thermal Cycler were 
processed using Microsoft Excel (2007) before GraphPad Prism V.7.05 (Graphpad Software, San 
Diego, CA, USA) was used for statistical analyses and to produce graphical illustrations of the 
data. To calculate relative gene expression, relative quantification (RelQ = 2^-cq) was calculated 
from the average cq of all three replicates before the values were normalised to the reference 
gene (arp). Change in target gene expression was calculated as a fold change relative to the 
solvent control (DMSO 0.1%). The data was then transformed (y=log2(y)) before a one-way 
ANOVA with Greenhouse-Geisser corrections and Dunnet’s multiple comparisons test was 
performed in order to calculate significant fold induction in the means of the test 
concentrations over the mean of the solvent control. 
For the MTT-data collected from the EnSpire 2300 Multilabel Reader (PerkinElmer), the mean 
blank values were subtracted from the mean of the test concentrations and then divided on 
the weight of the slice to get abs/mg slice. Fold change per mg slice relative to the solvent 




test. Transformation (y=log2(y)) and repetition of normality test was performed on non-normal 
distributed data. A one-way ANOVA with Dunnett’s multiple comparisons test was performed 
on normal distribution data, and Friedman’s test with Dunn’s multiple comparisons test was 
used on non-normal distributed data. 
 
 LUCIFERASE REPORTER GENE ASSAY  
3.2.1 EXPERIMENTAL DESIGN 
To further investigate the mixtures ability to activate the Ah-receptor, a luciferase reporter 
gene assay was conducted. Steps were performed every 24 hours, starting with seeding the 
cells into the wells, transfecting them with the necessary plasmids, ligand treatment and the 
final luminescence measurements. A cell viability assay was performed to assess the 
cytotoxicity of the concentrations used, and for this part, the cells were un-transfected, and 
instead kept in culture for 48 hours between seeding and ligand treatment (Figure 8). 
 
 
Figure 8: Flow chart of the process from seeding out the COS-7 cells to running the luminescence measurements 




In the luciferase assay, COS-7 simian cells transiently transfected with Atlantic cod Ahr2 and 
Atlantic cod Arnt were exposed to mixtures of B(a)P and PFAS. The same compounds were used 
as in Experiment 2, but with concentrations adapted to a luciferase reporter gene system (Table 
33). Cells were also exposed to B(a)P (0.008 - 10 µM) alone as it is a well-known agonist of 
gmAhr2a.  
For the co-exposures, [B(a)P] = 0.01 µM (~EC50) was used as the fixed concentration. This 
concentration was determined based on results from a previous exposure to B(a)P performed 
by Roger Lille-Langøy (See Appendix A). This concentration is high enough to show activation 
of the Ah-receptor on its own, but any agonistic or antagonistic effects of the PFAS would still 
be observable. DMSO (0,55%) was used as solvent control. The concentrations given for the 
PFAS-mix represent ΣPFAS, which means that the 10 µM exposure consists of 3.33 µM PFOS, 
3.33 µM PFOA and 3.33 µM PFNA, and so forth. Each concentration was added in triplicates on 
each plate, and the experiment was performed three times.  
Table 33: Ligand treatments and concentrations  


















DMSO (0.55%) x x x x x x 
BaP (0.01)  x x x x x 
PFOS (100, 50, 10, 2, 0.4, 0.08)   x    
PFOA (100, 50, 10, 2, 0.4, 0.08)    x   
PFNA (100, 50, 10, 2, 0.4, 0.08)     x  
       
PFOS (33.3, 16.66, 3.33, 0.666, 0.133, 0.026)      x 
PFOA (33.3, 16.66, 3.33, 0.666, 0.133, 0.026)      x 




3.2.2 PLASMID PREPARATION 
To prepare the receptor- and control plasmids necessary for the LRA, 250 µl E. coli culture 
previously transformed with the LRA plasmids (and stored in glycerol at -80°C) was added to 
250 ml LB medium (w/ 0.1 mg/ml ampicillin) and left to incubate at 250 RPM and 37 °C 
overnight. The over-night cultures ware collected, and optical density (OD) measured using an 
Ultrospec 10 cell density meter (Amersham Biosciences) and the plasmids were purified from 
the overnight culture using the NucleoBond® Xtra Midi plasmid purification kit (Macherey-
Nagel) following the producer’s protocol. This is a column-based assay, where the supernatant 
containing the plasmid DNA is applied to a silica column that binds the plasmid but lets the 
remaining components be washed out with a washing buffer. The plasmids prepared are listed 
in Table 23. To assess the integrity of the DNA, all five plasmids were controlled using agarose 
gel electrophoresis. This work was performed by Roger Lille-Langøy. A picture of the gel was 
obtained using GelDoc™ EX Imager (BioRad) and is attached in Appendix B.  
3.2.3 CULTIVATION OF COS-7 CELLS 
The COS-7 cells were kept in 37°C, normal atmosphere with 5% CO2, and split at a confluency 
of 80-90%. They are adherent and grow as a monolayer in a petri dish. To split the cells, the 
culture medium was removed, and the cells washed using 1X PBS (pH 7.4). To detach them 
from the 10 cm cell culture dish, they were treated with 2 ml trypsin-EDTA (0.05% trypsin, 
0.02% EDTA) for 1 minute in RT before the excess trypsin was removed and the plate incubated 
for 5 minutes at 37°C, normal atmosphere with 5% CO2. To further detach the cells, they were 
resuspended in culture medium and the medium was pipetted up and down onto the bottom 
of the dish a few times. The cells were seeded out onto new petri dishes in a 1:10 or 1:20 
dilution depending on the confluency and time until seeding. 
3.2.4 SEEDING OF COS-7 CELLS 
On the first day of the experiment, COS-7 cells were seeded out in a 96-well plate. The culture 
medium was removed from the cell culture dish, and the cells were washed and treated with 
trypsin as described in 3.3.3. The cells were then resuspended in culture medium and 
transferred to a centrifuge tube before the cells were counted. To make sure only living cells 




the dead cells. The cells were then counted using a gridded haemocytometer, and the cell 
suspension diluted to give a cell density of 10*104 cells/ml. 100 µl of the suspension was 
transferred to a 96-well plate using an electronic multichannel pipette giving a total number of 
10 000 cells per well. They were left to incubate for 24 hours at 5% CO2 and 37°C before they 
were transfected with plasmids.  
3.2.5 TRANSFECTION 
On day two, the cells were transfected with pcDNA3.1_gmAhr2a (receptor plasmid), 
pcDNA3.1_gmArnt, pGudLuc6.1 (reporter plasmid), pCMV-β-galactosidase (control plasmid), 
and pcDNA3.1 (expression vector plasmid). A transfection mix was prepared consisting of 
plasmids, transfection reagent (TransIT®LT-1 transfection kit, Mirus Bio), and serum-free 
medium (OptiMEM) according to Table 10. It was left to incubate for 30 minutes, before culture 
medium was added to the transfection mixture. The old culture medium was removed from 
the 96-well plates, and 100µl of the DMEM transfection medium was added to each well. The 
plates were then incubated for another 24 hours at 5% CO2 and 37 °C before ligand treatment.  
3.2.6 LIGAND TREATMENT  
On day three, 24 hours after the transfection, the cells were treated with the compounds of 
interest to detect any agonistic or antagonistic effects. To do this, a 2x ligand solution in DMEM 
w/o phenol red was prepared in a 96-well plate suitable for dilution. The solution was serial 
diluted once five-fold and then two-fold giving the concentrations shown in Table 33. The old 
culture medium was then removed from the 96-well plate containing COS-7 cells, and replaced 
with 100 µl new culture medium (DMEM w/o phenol red and super stripped foetal bovine 
serum (FBS)) before 100 µl of the 2x dilution series was added giving the desired concentrations 
in each well. The plate was shaken carefully from side to side a couple of times and again 
incubated for 24 hours at 5% CO2 and 37°C before cell lysis and measurement of luciferase- and 





3.2.7 LYSIS AND MEASUREMENTS 
On day four, the old medium was removed from the 96-well plate, and the cells were lysed to 
measure the luciferase- and β-galactosidase-activity. A lysis reagent was prepared as described 
in Table 14, and 125 µl of this mixture was added to each well before the plates were left to 
incubate in RT for 30 minutes on gentle shaking. In the meantime, a β-Gal reagent and 
luciferase reagent was prepared as described in Table 15 and 16 respectively. After 30 minutes 
of incubation, 50 µl of the lysate from the original 96-well plate was transferred to the wells of 
one white and one clear luminescence plate. The white plate was used to measure luciferase 
activity, by adding 100 µl of the luciferase reagent to the 50 µl of lysate. The emitted light was 
measured immediately using a Perkin Elmer Enspire 2300 Multilabel Plate Reader.  To the clear 
plate, 100 µl of the β-Gal reagent was added to the 50 µl lysate and set to incubate for 20 
minutes. The absorbance was measured at a wavelength of 405 nm. This part of the assay was 
performed to control proper transfection of the plasmids.  
3.2.8 CELL VIABILITY ASSAY  
To determine if the concentrations used were cytotoxic, a cell viability assay was performed 
assessing two factors: the metabolic activity, and the cell membrane integrity. The metabolic 
activity of the cells can be measured using resazurin. This is a low-fluorescent compound that 
dehydrogenase enzymes in living cells will reduce to form resorufin, which is highly fluorescent. 
To assess the membrane integrity, 5-carboxyfluorescein diacetate (CFDA-AM) was used. This is 
a non-fluorescent compound that will cross the cell membrane by passive transport and be 
converted to the fluorescent dye carboxyfluorescein by non-specific esterases, and the amount 
of fluorescence will reflect the enzyme activity. 
COS-7 cells were seeded out in 96 well-plates as described in 3.3.4 and left to incubate for 48 
hours at 5% CO2 and 37°C. The culture medium was changed after the first 24 hours. After the 
48 hours, the cells were treated with the compounds of interest as described in 3.3.6 before 
additional 24 hours of incubation. Exposure to Triton® X100 (0.5%) was used as a positive 
control of cytotoxicity. On the last day, the cells were washed in 1X PBS (pH 7.4) before the 
resazurin-CFDA-AM reaction solution (Table 21) was added. The plates were incubated for 1 
hour, before fluorescence (resazurin) was measured at 530/590 nm (ex/em) and at 485/530 




3.2.9 DATA TREATMENT AND STATISTICS  
The LRA readings collected from the EnSpire 2300 Multilabel Reader (PerkinElmer) were initially 
processed using Microsoft Excel (2007). The ligand induced luciferase activity in each well was 
normalised by dividing by the corresponding β-galactosidase readings for correction of 
transfection efficiency. These values were then divided by solvent control (0.5% DMSO) 
averages to calculate fold induction in ligand induced luciferase activity. In GraphPad Prism 
V.7.05, normality was tested using D’Agostino & Pearson normality test. A one-way ANOVA 
with Dunnett’s multiple comparisons test was performed on normal distribution data, and 
Kruskal Wallis test with Dunn’s multiple comparisons test on non-normal distribution data. 
The cell viability fluorescence reading (both Resazurin- and CFDA-AM-numbers) in each well 
was divided by the mean of the corresponding DMSO-values to calculate the percentage of 











 ACTIVATION OF THE AHR AND PPAR SIGNALLING PATHWAYS IN PRECISION 
CUT LIVER SLICES 
To assess if exposure to PFAS and B(a)P could activate the Ahr or PPAR signalling pathways ex 
vivo, precision cut liver slices of Atlantic cod were prepared and exposed to increasing 
concentrations of PFOS, PFOA, PFNA, and B(a)P. RNA was thereafter isolated from exposed 
PCLS to assess alterations in expression of Ahr and Pparα target genes with qPCR. The purity 
and integrity of the RNA-samples were monitored with spectrophotometry and gel 
electrophoresis, respectively, before cDNA synthesis and qPCR analyses. All the A260/280-ratios 
recorded for the RNA-samples were above 1.8, indicating that the isolated RNA contained low 
or no contamination of DNA. The A260/230-ratios varied more, but most samples were close to 
2. The lower A260/230-ratios could be due to some contamination of proteins, or a reagent such 
as phenol. An agarose gel electrophoresis with a 0.75% agarose gel revealed that all samples 
contained two distinct bands at 1200 and 2300 bp, representing 18S and 28S ribosomal RNA, 
respectively (Figure 9), and indicating that the RNA has been successfully separated and the 
integrity of the RNA is intact.  
 
Figure 9: Control of RNA integrity. The figure shows a representative selection of samples of RNA isolated from 
Atlantic cod PCLS analysed with agarose gel electrophoresis. The liver slices were exposed to solvent control, 0.1% 
DMSO (sample 1-3), 1 µM B(a)P (sample 4-7), 1 µM B(a)P +10 µM PFNA (sample 8, 9), 1µM B(a)P + 100 µM PFNA 
(sample 10), 1 µM B(a)P + 10 µM PFAS-mix (sample 11, 12), 1 µM B(a)P + 50 µM PFAS-mix (sample 13, 14), and 1 
µM B(a)P + 100 µM PFAS-mix (sample 15, 16). 0.5 µl RNA was added to each well of a 0.75% agarose gel.   M = 2-





Gene expression in the liver slices after exposure was measured using qPCR, assessing the 
induction of the Ahr target-gene cyp1a, and the mammalian Pparα target genes acox1 and acly. 
B(a)P is known to be a strong activator of the Ahr-pathway and was used as an inducer of cyp1a 
expression. As expected, the qPCR-results demonstrated significantly increased expression of 
cyp1a in comparison to solvent control for all concentrations used (significant for 1 µM and 10 
µM) (Figure 10). The LDH assay was used to monitor the viability of the liver slices and showed 
no apparent cytotoxicity for any of the concentrations (Figure 11). Based on these results, 1 µM 
B(a)P was chosen as the fixed B(a)P-concentration to be used for the co-exposures with PFAS. 
This concentration was high enough to induce expression of cyp1a and also considered to be 
low enough for potential mixture effects to be visible and to avoid cytotoxicity in co-exposures. 
 
 
Figure 10: Gene expression of cyp1a in Atlantic cod PCLS exposed to B(a)P. PCLS from juvenile cod (n=4) were 
exposed to B(a)P (0.1, 1 and 10 µM) for 48 hours. The graph shows fold change transcript levels +/- SEM relative 
to solvent control (0.1% DMSO) in transcription levels of cyp1a normalized to the reference gene arp. Statistical 





Figure 11: Cell viability assay. Culture medium collected from Atlantic cod PCLS-exposures was used to measure 
LDH activity as an indicator of damaged cell membranes and a proxy of cytotoxicity. The graph shows relative 
viability (%) +/- SEM in comparison to solvent control (0.1% DMSO). Cytotoxic response was defined as decrease in 
fluorescence compared to solvent control, which is adjusted to 100%. No significant differences were found using 
one-way ANOVA. 
 
When assessing activation of the Ahr signalling pathway, all PFAS exposures of PCLS showed a 
trend in increase in cyp1a expression. The highest concentrations (100 µM) of PFOS and PFOA 
demonstrated also a statistically significant difference in cyp1a expression in comparison to 
solvent control, with 1.44 and 2.3 in fold change in transcript levels, respectively (Figure 12 A, 
and B). Furthermore, exposure to PFNA showed significant differences at 10 and 100 µM with 
a fold change of 1.75 and 2.08 in cyp1a expression, respectively. (Figure 12 C). Exposure to a 
PFAS-mix showed a trend of a dose-dependent increase in cyp1a levels, but no statistical 






Figure 12: Expression of cyp1a in Atlantic cod PCLS exposed to PFOS, PFOA, PFNA and PFAS-mix. PCLS from juvenile 
cod (n=4) were exposed to increasing concentrations of PFOS (A), PFOA (B), PFNA (C), and a PFAS-mix (D) (10, 50 
and 100 µM) for 48 hours. The graph shows fold change transcript levels +/- SEM relative to solvent control (0.1% 
DMSO) in transcription levels of cyp1a normalized to the reference gene arp. Statistical significance is defined as 
change in gene expression compared to solvent control and is indicated as: * = p ≤ .05, **= p ≤ .01, ***= p ≤ .001, 
****= p ≤ .0001. 
 
Activation of the PPARα signalling pathway was also assessed using qPCR for quantifying the 
expression of acox1 and acly, which are both central genes in lipid metabolism. Besides 
exposure to PFOS, which showed no increase in the expression of acox1, all concentrations of 
PFNA, in addition to the highest concentration used with PFOA (100 µM), produced significant 
differences in acox1 expression in comparison to solvent control (1.77, 1.51 and 1.55 in fold 
change, Figure 13 C) (1.27 in fold change, Figure 13 B). Neither of the single PFAS exposures, 
nor exposure to the PFAS-mixture, produced any significant differences compared to solvent 
control in the expression of acly (Figure 14).  





Figure 13: Expression of acox1 in Atlantic cod PCLS exposed to PFOS, PFOA, PFNA, and a PFAS-mix. PCLS from 
juvenile cod (n=4) were exposed to increasing concentrations of PFOS (A), PFOA (B), PFNA (C), and a PFAS-mix (D) 
(10, 50 and 100 µM) for 48 hours. The graph shows fold change transcript levels +/- SEM relative to solvent control 
(0.1% DMSO) in transcription levels of acox1 normalized to the reference gene arp. Statistical significance is defined 
as change in gene expression compared to solvent control and is indicated as: * = p ≤ .05, **= p ≤ .01, ***= p ≤ 





Figure 14: Expression of acly in Atlantic cod PCLS exposed to PFOS, PFOA, PFNA and a PFAS-mix. PCLS from juvenile 
cod (n=4) were exposed to increasing concentrations of PFOS (A), PFOA (B), PFNA (C), and a PFAS-mix (D) (10, 50 
and 100 µM) for 48 hours. The graph shows fold change transcript levels +/- SEM relative to solvent control (0.1% 
DMSO) in transcription levels of acly normalized to the reference gene arp. Statistical significance is defined as 
change in gene expression compared to solvent control and is indicated as: * = p ≤ .05, **= p ≤ .01, ***= p ≤ .001, 












To detect putative mixture effects, combination exposures of B(a)P and the three PFAS of 
interest were performed and assessing alterations in the gene expression of the same genes as 
in the single PFAS exposures. As demonstrated above, B(a)P induced cyp1a expression at a 
concentration of 1 µM. A trend of stronger induction of cyp1a compared to B(a)P exposure 
alone was observed by co-exposure with both single PFAS compounds and the PFAS-mix. For 
expression of cyp1a, all exposure scenarios showed significant difference to solvent control 
(highest fold change 88, 89, 86, and 123 for B(a)P + PFOS, PFOA, PFNA or PFAS-mix respectively) 
(Figure 15). However, significant differences between any of the co-exposures and single 
exposure to B(a)P was only observed for 50 µM PFOA (Figure 15 B).  
 
 
Figure 15: Expression of cyp1a in Atlantic cod PCLS co-exposed to B(a)P and PFOS, PFOA, PFNA and a PFAS-mix. 
PCLS from juvenile cod (n=4 or n=6) were exposed to a fixed concentration of B(a)P (1 µM) and increasing 
concentrations of PFOS (A), PFOA (B), PFNA (C), or a PFAS-mix (D) (10, 50 and 100 µM) for 48 hours. The graph 
shows fold change transcript levels +/- SEM relative to solvent control (0.1% DMSO) in transcription levels of cyp1a 
normalized to the reference gene arp. Statistical significance is defined as change in gene expression compared to 
solvent control and is indicated as: * = p ≤ .05, **= p ≤ .01, ***= p ≤ .001, ****= p ≤ .0001. Significant difference 




acox1 and acly also showed some trends of an increased gene expression with combined PFAS 
and B(a)P exposures, compared to solvent control and B(a)P exposure alone. However, no 
statistically significant differences were revealed for expression of acox1 in exposure to B(a)P + 
PFOS, PFOA or PFNA. Exposure to B(a)P + 50 and 100 µM PFAS-mix showed significant increase 
in acox1 expression compared to single B(a)P-exposure (Figure 16 D). Expression of acly did not 
change significantly in combined exposures to B(a)P and PFOS, PFOA or PFAS-mix in comparison 
to solvent control or single exposures to B(a)P (Figure 17 A, B, D). The gene expression in 50 
µM exposure of PFNA in combination with B(a)P, however, showed to be significantly different 
to the expression determined in the single exposure of B(a)P (Figure 17 C).  
 
 
Figure 16: Expression of acox1 in Atlantic cod PCLS co-exposed to B(a)P and PFOS, PFOA, PFNA and a PFAS-mix. 
PCLS from juvenile cod (n=4 or n=6) were exposed to a fixed concentration of B(a)P (1 µM) and increasing 
concentrations of PFOS (A), PFOA (B), PFNA (C), or a PFAS-mix (D) (10, 50 and 100 µM) for 48 hours. The graph 
shows fold change transcript levels +/- SEM relative to solvent control (0.1% DMSO) in transcription levels of acox1 
normalized to the reference gene arp. Statistical significance is defined as change in gene expression compared to 
solvent control and is indicated as: * = p ≤ .05, **= p ≤ .01, ***= p ≤ .001, ****= p ≤ .0001. Significant difference 





Figure 17: Expression of acly in Atlantic cod PCLS co-exposed to B(a)P and PFOS, PFOA, PFNA and a PFAS-mix. PCLS 
from juvenile cod (n=4 or n=6) were exposed to a fixed concentration of B(a)P (1µM) and increasing concentrations 
of PFOS (A), PFOA (B), PFNA (C), or a PFAS-mix (D) (10, 50 and 100 µM) for 48 hours. The graph shows fold change 
transcript levels +/- SEM relative to solvent control (0.1% DMSO) in transcription levels of acly normalized to the 
reference gene arp. Statistical significance is defined as change in gene expression compared to solvent control and 
is indicated as: * = p ≤ .05, **= p ≤ .01, ***= p ≤ .001, ****= p ≤ .0001. Significant difference to 1 µM B(a)P (p ≤ 




 CELL VIABILITY ASSAY OF PCLS EXPOSURES 
An MTT assay was conducted to assess for putative cytotoxic effects induced by the exposure 
regimes used with the PCLS. DMSO (0.1%) was used as solvent control and (1%) Triton® X100 
was used as positive control for cytotoxicity. Cytotoxicity was defined as the decrease in 
fluorescence compared to the solvent control (0.1% DMSO). For the MTT assays of B(a)P + PFOS 
and B(a)P + PFOA exposures, Triton® X100 was not included. The MTT assays showed no 
cytotoxicity for any of the different exposure regimes (Figure 18 and 19).  
 
Figure 18: MTT cell viability assay. Atlantic cod PCLS were exposed to the same compounds/mixtures and 
concentrations used with PCLS in Experiment 1 and indicated in the figure. Culture medium with 0.1% DMSO was 
used as negative control, and Triton (1%) used as positive control. Cytotoxic response is defined as decrease in 
fluorescence compared to solvent control (+/- SEM), which is adjusted to 100% and indicated by the dotted line. No 





Figure 19: MTT cell viability assay. Precision cut liver slices were exposed to the same compounds/mixtures and 
concentrations used with PCLS in Experiment 2 and indicated in the figure. Culture medium with 0.1% DMSO was 
used as negative control, and Triton (1%) used as positive control. Cytotoxic response is defined as decrease in 
fluorescence compared to solvent control (+/- SEM), which was adjusted to 100% indicated by the dotted line. No 







 AHR TRANSCRIPTIONAL ACTIVITY IN COS7-CELLS 
The putative effects of B(a)P and PFAS were further investigated using a luciferase reporter 
gene assay to study modulation of Atlantic cod Ahr2 activation. Transfected COS-7 cells were 
exposed to the compounds of interest for 24 hours before activation of Ahr2a was measured 
indirectly using a luciferase reporter gene assay. As expected, the exposure to B(a)P showed a 
dose-dependent increase in activation of the Ah-receptor (Figure 20 A). All concentrations in 
each exposure scenario with combinations of B(a)P and PFAS also showed significant difference 
in activation of Ahr compared to solvent control (0.1% DMSO). However, none of the combined 
exposures showed significant difference in receptor activation compared to exposure to B(a)P 
alone (Figure 20 B-E).  
 
Figure 20: Ligand activation in gmAhr2a-transfected COS-7 cells co-exposed to B(a)P in addition to either PFOS, 
PFOA, PFNA or a PFAS-mix. COS-7 cells (n=9) were transfected with receptor plasmid (pcDNA3.1_gmAhr2a; 
pcDNA3.1_gmArnt), reporter plasmid (pGudLuc6.1), expression vector (pcDNA3.1) and control plasmid (pCMV-β-
galacosidase). The cells were exposed to a fixed concentration of B(a)P (1 nM) and increasing concentrations of  
either PFOS, PFOA, PFNA or a PFAS-mix as indicated (0.08, 0.4, 2.0, 10, 50 and 100 µM) for 24 hours (graphs B to 
E). Exposure to B(a)P (0.004, 0.008, 0.04, 0.2, 1.0, 5.0, and 10 µM, n=6) was done to show activation of Aryl 
hydrocarbon receptor (graph A). The graphs show fold change +/- SEM relative to solvent control (0.1% DMSO) in 
activation of Ahr2a. Statistical significance is defined as change in receptor activation compared to solvent control, 




 CELL VIABILITY ASSAY OF COS-7 CELL EXPOSURE 
To assess if the concentrations used in the luciferase reporter gene assays produced cytotoxic 
effects in the COS-7 cells, a cell viability assay measuring the metabolic activity and the 
membrane integrity was conducted. Non-transfected COS-7 cells were exposed to the ligands 
in the same concentrations as used in the luciferase reporter gene assay. In addition, a positive 
control for cytotoxicity (Triton 0.1%) was added. Cytotoxicity was defined as significant 
difference to solvent control (0.5% DMSO). If there was a significant decrease in the viability of 
the cells, this could affect the receptor activation, and possibly result in a reduced activation 
profile. The results showed that there was a significant decrease in metabolic activity for most 
concentrations in all of the four exposure scenarios. All scenarios produced a “dip” in metabolic 
activity on the medial concentrations, but no cytotoxicity was revealed for the highest 
concentrations used (100 µM) (Figure 21). The lowest relative fluorescence was 89.7% (B(a)P + 
PFOS 10µM), 81.4% (B(a)P + PFOA 2µM), 78.2% (B(a)P + PFNA 2µM), and 89.16% (B(a)P + PFAS-
mix 0.4µM). 
 
Figure 21: Metabolic activity in COS-7 cells after ligand exposure. COS-7 cells were exposed to the same 
concentrations as used for the luciferase reporter gene assay. DMSO (0.5%) was used as solvent control, and Triton 
(0.5%) used as positive control. Cytotoxic response is defined as the decrease in fluorescence compared to negative 
control (0.5% DMSO) (+/- SEM) which is adjusted to 100% and indicated by the dotted line. Significance is indicated 




The same “dip” in relative fluorescence was also revealed in the results for the membrane 
integrity (Figure 22), but for exposure to B(a)P in combination with PFOA, PFNA or PFAS-mix, 
all concentrations showed to be cytotoxic, including exposure to B(a)P alone. The lowest 
relative fluorescence was 77.0% (B(a)P + PFOS 10µM), 67.6% (B(a)P + PFOA 10µM), 62.8% 
(B(a)P + PFNA 2µM), and 77.3% (B(a)P + PFAS-mix 2µM). 
 
 
Figure 22: Membrane integrity in COS-7 cells after ligand exposure. COS-7 cells were exposed to the same 
concentrations as used for the luciferase reporter gene assay. DMSO (0.5%) was used as solvent control, and Triton 
(0.5%) used as positive control of cytotoxicity. Cytotoxic response is defined as the decrease in fluorescence 
compared to negative control (0.5% DMSO) (+/- SEM) which is adjusted to 100% and indicated by the dotted line. 
Significance is indicated as * = p ≤ .05, **= p ≤ .01, ***= p ≤ .001, ****= p ≤ .0001. One-way ANOVA or Kruskal-









Most contaminants of emerging concern are man-made. When introducing these compounds 
to consumers and our environment, it comes with a responsibility of obtaining the necessary 
knowledge of their toxicities and to perform comprehensive risk assessments to limit potential 
negative impacts of these compounds on nature and wildlife. It is therefore important to have 
sufficient insights into what the effects of these compounds might be, and if, or how, different 
combinations of compounds can make an exposure scenario more severe for biota. To do this, 
extensive testing of toxicity must be performed to set proper safety thresholds and determine 
Environmental Quality Standards. The recent regulation implemented by EFSA takes these 
potential effects into account. The 2018-opinion set separate TWI values for PFOA and PFOS, 
but the new safety threshold of 4.4 ng/kg bodyweight applies to PFAS as a group and thus 
represent a new framework for evaluating chemical mixtures in food and feed (Mixtures 
Methodology Equips EFSA for Multiple Chemicals, 2019).  
Epidemiologic studies of prenatal exposure to PFAS show negative associations between PFAS 
levels in maternal blood plasma and foetal growth, as well as showing endocrine-disrupting 
potential through altering foetal gonadotropin levels and thyroid hormones through affecting 
GH3 cell growth and proliferation (Long et al., 2013; Nian et al., 2020; Verner et al., n.d.), and 
altering normal functioning of female gonads (Khan et al., 2020). B(a)P has also been shown to 
produce developmental toxicity on its own, including in Atlantic cod, where B(a)P can cause 
premature ovarian failure and tumour genesis (Drwal et al., 2019; Lim et al., 2013). As these 
chemicals already affect various biological pathways on their own, mixture effects between the 
two groups could potentially cause adverse outcomes, especially as sensitive periods of an 
organism such as during the early developmental stages. As limited knowledge exists when it 
comes to mixture effects, the aim of this study was to characterise toxicological effects in 
Atlantic cod after co-exposure to three different PFAS molecules and the PAH B(a)P. The focus 
of this thesis was on potential changes in expression levels of genes relevant for the 
biotransformation of xenobiotics (cyp1a) and the energy metabolism (acly and acox1), which 
are two cellular processes that previously have been found to be affected by PAH and PFAS 
exposure (Krøvel et al., 2008; Long et al., 2013; Takacs & Abbott, 2007; Whitlock, 1999). 




 ACTIVATION OF THE AHR SIGNALLING PATHWAY  
As expected, B(a)P exposure induced cyp1a expression in PCLS, which also has been shown 
previously by (Yadetie et al., 2018). In the same study, B(a)P also demonstrated the ability to 
interact with other compounds, producing anti-estrogenic effects in PCLS when co-exposed 
with ethynylestradiol (EE2) (Ibid.). The MTT assay conducted on the PCLS samples in this thesis 
showed that neither of the concentrations used of B(a)P and PFAS were cytotoxic to the liver 
slices. Furthermore, the results of the gene expression analyses revealed that there was an 
increase in the expression of cyp1a in PCLS with exposure to increasing concentrations of PFAS, 
and statistical significance was demonstrated for PFOS, PFOA and PFNA (100 µM). Induction of 
cytochrome P450 enzymes by PFASs has also been shown in mouse liver through activation of 
Pparα, and in chicken embryo hepatocyte cultures as a result of various transcriptional 
responses (Cheng & Klaassen, 2008; Hickey et al., 2009). PFAS-mediated induction of Cyp1a 
expression has also been demonstrated in several fish species, e.g zebrafish and marine 
medaka (Oryzias melastigma), along with the activation and inhibition of several other genes 
(Krøvel et al., 2008; Lee et al., 2020). Several studies performed on mammals have shown that 
PFOS is not able to induce expression of cyp1a, while it has been demonstrated to inhabit the 
ability to induce cyp1a in several fish species, suggesting that there are species differences in 
the transcriptional responses (Ibid.). Krøvel et al. (2008) used Atlantic salmon, and showed that 
PFOS induced cyp1a in hepatocytes, as was also shown in this thesis on PCLS from Atlantic cod. 
In this thesis, co-exposure between B(a)P and all four PFAS variations showed trends of an 
increased cyp1a expression that was higher than an additive response, but with statistical 
significance only for B(a)P + PFOA (50 µM) in comparison to B(a)P alone. This represents an 
apparent synergistic effect between the three relevant PFAS congeners and B(a)P, indicating 
that these two groups of compounds potentially could be of a higher risk to wildlife when 
present in mixtures. Such mixture-specific effects between PFASs and PAHs have also been 
shown in zebrafish embryos, where mixtures of PFAS and PCB126 induced a downregulation in 
expression of cyp1a, and up-regulation of glutathione peroxidase 1a (gpx1) compared to single 
exposures of PCB126 (Blanc et al., 2017), although the developmental stage and species 




 ACTIVATION OF THE PPARA SIGNALLING PATHWAY  
It has previously been shown that the carboxylic PFAS congeners PFOA and PFNA transactivate 
the Atlantic cod Ppara1 in vitro, while the sulfonic PFOS does not (Söderström, 2017). The 
results from my thesis further support these data, as there was a trend of an increase in 
expression of the Pparα target genes acox1 and acly after exposure of PCLS to PFOA, PFNA, and 
the PFAS-mix. For acox1 significant induction was shown for PFOA and PFNA, while no such 
trends were observed when exposed to PFOS alone. When it comes to the co-exposures of 
B(a)P and PFASs, these combinations did not seem to have any further effects on the activation 
of Pparα, except for the highest concentrations of the PFAS-mix + B(a)P. This exposure regime 
produced significantly higher expression of acox1 than B(a)P alone. The same effect was 
observed for the expression of acly, as exposure to 50 µM PFNA was significantly different from 
the expression of acly revealed in B(a)P-exposed PCLS. Although the tendencies that have been 
shown here are generally weak, these ex vivo results are in agreement with the work of (Dale 
et al., 2020), where activation of the Pparα signalling pathway was revealed by observing 
upregulation of enzymes in fatty acid degradation pathways after in vivo exposure of Atlantic 
cod to mixtures of PAHs and PFASs.  
 AHR TRANSCRIPTIONAL ACTIVITY IN COS7-CELLS 
In the luciferase reporter gene assay, B(a)P activated the Atlantic cod Ah receptor as expected 
and previously demonstrated (Aranguren-Abadía et al., 2020). Based on the PCLS-results, it 
could also be expected that a similar trend of further receptor activation could be promoted by 
co-exposures with PFASs, but no further activation of Ahr in combination with the PFAS 
compounds was revealed. On the contrary, the higher concentrations showed a trend of 
decrease in receptor activation. These results could be due to cytotoxicity, although the three 
PFAS-concentrations used in the PCLS-system corresponded to the highest concentrations used 
in the Luciferase-based system, and the fixed B(a)P concentration used on the COS-7 cells was 
100 times lower than the B(a)P-concentration used with the PCLS. However, the cell viability 
assays performed on the COS-7 cells showed that the concentrations used were in fact 
cytotoxic. There was a significant reduction in metabolic activity and an even higher reduction 
in membrane integrity for most concentrations used for all exposure compounds. PFASs are 




leukocytes after exposure to PFOS, and in microbial membranes of Aliivibrio fischeri as they 
were more permeable to semi-membrane permeable dye after PFAS exposure (Fitzgerald et 
al., 2017; Hu et al., 2003). Since significant reduction in membrane integrity was observed 
already at 10 nM B(a)P exposure without the addition of PFAS congeners, the fixed B(a)P 
concentration was apparently high enough to affect the cell viability. As no cytotoxicity was 
shown in the PCLS exposures, biotransformation of compounds could be central as this could 
occur in the liver slices, but not as likely in the COS-7 cell system. The cytotoxicity could explain 
the reduction in receptor activation measured from the highest concentrations in the luciferase 
assay, and potentially the lack of any further receptor activation for the lower concentrations. 
 COMMENTS ON THE SYSTEMS USED 
The two systems used represent two different approaches to answer the questions of interest, 
yet there are differences in the results, which may be caused by the set-up of the luciferase 
system. Cytotoxicity was shown in the exposure of COS-7 cells and not in any of the PCLS-
exposures despite the fact that the concentrations used on the COS-7 cells were equal to or 
lower than the concentrations used on the PCLS. The liver slices could simply be more robust 
than the COS-7 cells as they inhabit most of the complex multi-cellular structure of the liver as 
found in vivo, including erythrocytes, fat-storing cells, and endothelial cells. In addition, the 
slices have not undergone any form of handling or stressors before ligand exposure such as cell 
cultures have. One essential difference between the two systems is that biotransformation can 
occur in the liver slices and most likely to a much lesser extent in the COS-7 cells. This means 
that some of the compounds used for exposure could be transformed within the cells by 
enzymes induced through the activation of e.g. the Ahr signalling pathway, such as CYP1A. If 
e.g. B(a)P is metabolised fast enough, this could result in a difference in the actual 
concentrations present in the cells of the specific compounds, and the COS-7 cells could in fact 
have been exposed to higher effective concentrations than the PCLS. Although the luciferase-
based reporter gene assay is a well-established system for conducting high-throughput ligand 
screening it is a limited model as it does not account for metabolic activity, and the 





In general, the results obtained in this thesis indicate that the PFASs used in the experiments 
could in fact induce the activation of cyp1a, and also enhance the toxicity of B(a)P through 
stronger induction of cyp1a. The PFASs could also possibly interfere with the lipid metabolism 
through the Pparα signalling pathway. The lack of receptor activation by co-exposure during 
luciferase reporter gene assay could be explained by high cytotoxicity in most conditions used, 
which again could be confirmed by adjusting the concentrations used and repeat these 
experiments. The experiments performed in this master’s thesis have accentuated that mixture 
effects is a field that must be explored further, as there are indications that combinations of 
B(a)P and the PFASs of interest could indeed give rise to responses beyond additive effects. 
Regardless of the room for improvement, the results provide additional information that 
enhances the importance of integrating mixture effects into the toxicity testing and risk 
assessment of chemicals.  
 FUTURE PERSPECTIVES 
There are several steps that can be taken to further investigate different combinations of PAHs 
and PFAS and to see whether mixture effects arise. Even though this thesis was a continuation 
of an in vivo experiment, a natural next step would be to test the findings for these specific 
combinations in vivo to look for systemic responses after sub-chronic or chronic exposures. As 
there could be differences in effects between organisms, the use of human or other 
mammalian receptors in similar exposure scenarios could also be interesting for obtaining a 
clearer picture of the risk these mixtures pose to humans or other organisms. For instance, 
PFOS has shown to activate human Pparα (Behr et al., 2020) although it does not activate 
mouse and Atlantic cod Pparα (Söderström, 2017; Takacs & Abbott, 2007). Performing a 
repeated version of the luciferase reporter gene assay using lower concentrations of B(a)P 
and/or the various PFAS congeners in order to avoid cytotoxic effects and get more valid results 
would also be beneficial, especially regarding PFOS-exposure to investigate the mechanisms 
behind PFOS mediated induction of cyp1a. Many of the most common PFASs are also replaced 




above 0.025 ng/kg product in chemicals and consumer products. Thus, to include shorter-
chained PFAS molecules in similar experimental designs, could aid to assess if the replacement 
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Figure B1: Control of the conformation of midiprep plasmids used for transfection in luciferase reporter gene assay.  
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